Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

SEC Filings

Select the filing type and date range you wish to view from the drop-down menus below.

NASDAQLPCN
FormDescriptionDateFormat
S-1/AAmended Registration statement for face-amount certificate companiesDec 29, 2011View HTMLDownload DOCDownload PDFDownload XLS
S-1/AAmended Registration statement for face-amount certificate companiesDec 29, 2011View HTMLDownload DOCDownload PDFDownload XLS
UPLOADCorrespondence from the SEC to the FilerDec 27, 2011Download DOCDownload PDF
S-1Registration statement for face-amount certificate companiesNov 30, 2011View HTMLDownload DOCDownload PDFDownload XLS